United States v. Team Finance

80 F.4th 571
CourtCourt of Appeals for the Fifth Circuit
DecidedAugust 31, 2023
Docket22-40707
StatusPublished
Cited by10 cases

This text of 80 F.4th 571 (United States v. Team Finance) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Team Finance, 80 F.4th 571 (5th Cir. 2023).

Opinion

Case: 22-40707 Document: 00516879635 Page: 1 Date Filed: 08/31/2023

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit

____________ FILED August 31, 2023 No. 22-40707 Lyle W. Cayce ____________ Clerk

United States of America, ex rel Caleb Hernandez and Jason Whaley, Relators, Et al.,

Plaintiff,

versus

Team Finance, L.L.C.; Team Health, Incorporated; Team Health Holdings, Incorporated; Ameriteam Services, L.L.C.; HCFS Health Care Financial Services, L.L.C.; Quantum Plus, L.L.C., doing business as Teamhealth West,

Defendants—Appellees,

Loren Adler,

Movant—Appellant. ______________________________

Appeal from the United States District Court for the Eastern District of Texas USDC No. 2:16-CV-432 ______________________________

Before Wiener, Graves, and Douglas, Circuit Judges. Jacques L. Wiener, Jr., Circuit Judge: Case: 22-40707 Document: 00516879635 Page: 2 Date Filed: 08/31/2023

No. 22-40707

Movant-Appellant Loren Adler seeks to permissively intervene in this closed matter to challenge the sealing of records. The district court denied Adler’s intervention on three independent grounds, each of which is a subject of this appeal. Although courts are afforded great discretion in deciding intervention pursuant to Federal Rule of Civil Procedure 24(b), the district court’s reasoning was premised on several significant errors. We reverse and remand. I. The underlying case against Defendants-Appellees TeamHealth—a group of private equity-owned healthcare entities—was brought under the qui tam provisions of the False Claims Act, 31 U.S.C. § 3729 et seq. Two former TeamHealth employees, Caleb Hernandez and Jason Whaley (together, the “Relators”), alleged that TeamHealth routinely billed for non- existent doctor examinations and critical care services. The matter was unsealed in 2018 after federal and state governments declined to intervene. The Relators moved forward with their case, which survived dismissal and proceeded through extensive discovery. The parties jointly agreed to a protective order but disputed its contours. For example, TeamHealth fought to use a special designation of “Highly Confidential – Attorneys’ Eyes Only” to protect “highly competitive information.” Relators contended that this designation was unnecessary because the case “d[id] not involve an intellectual property or trade secret[s].” The district court ruled that TeamHealth could implement its requested designation as necessary. Throughout 2020, Relators proceeded to challenge the confidentiality designations of specific swathes of documents. TeamHealth responded by seeking additional protective orders. The district court held a hearing and granted TeamHealth’s requests for protection with the caveat that the

2 Case: 22-40707 Document: 00516879635 Page: 3 Date Filed: 08/31/2023

documents could be reconsidered later in the context of trial. As the case proceeded, the district court entered orders sealing relevant documents. Shortly before trial in July 2021, the parties settled this case. The settlement required TeamHealth to pay a total of $48 million to the United States and Relators. The district court entered the parties’ stipulation for dismissal, but “retain[ed] jurisdiction for the purpose of enforcing the settlement agreement between the parties.” On December 14, 2021, Adler moved to intervene permissively pursuant to Federal Rule of Civil Procedure 24(b)(1) for the limited purpose of unsealing records. As “a health care economist who focuses his work on health care pricing,” Adler had previously “studied and published extensively on TeamHealth” and other private equity-owned companies. Adler’s statements online make clear that he followed litigation related to TeamHealth. He submitted that “the information in this case would be highly informative to his research” and “would be instructive as to how providers bill for services generally,” which he contends is of interest to the general public. The district court denied Adler’s motion to intervene on three independent grounds: (1) lack of standing, (2) a failure to demonstrate “a claim or defense that shares with the main action a common question of law or fact,” and (3) untimeliness. Adler now appeals that decision. II. Adler moved to intervene in this matter pursuant to Rule 24(b)(1), which states, “[o]n timely motion, the court may permit anyone to intervene who . . . has a claim or defense that shares with the main action a common question of law or fact.” Fed. R. Civ. P. 24(b)(1) (“PERMISSIVE INTERVENTION . . . In General.”).

3 Case: 22-40707 Document: 00516879635 Page: 4 Date Filed: 08/31/2023

Adler raises three issues on appeal related to each of the district court’s reasons for denying his motion: (1) standing, which is required to intervene in a closed case; (2) adherence to Rule 24(b)(1), which requires that Adler have a “claim or defense that shares with the main action a common question of law or fact”; and (3) timeliness, which considers delay in filing for intervention and any related prejudice to the litigants. 1 These issues were sufficiently raised and argued below in Adler’s motion to intervene. While the district court is afforded great discretion in deciding permissive intervention, its reasons for denial were premised on erroneous statements of law which warrant reversal. See United States v. Chambliss, 948 F.3d 691, 693 (5th Cir. 2020) (A district court abuses its discretion when it “bases its decision on an error of law or a clearly erroneous assessment of the evidence.” (quoting United States v. Chapple, 847 F.3d 227, 229 (5th Cir. 2017))). A. We first examine standing. Clear precedent dictates that, “[i]n the absence of a live controversy in a pending case, an intervenor would need standing to intervene.” Newby v. Enron Corp., 443 F.3d 416, 422 (5th Cir. 2006) (discussing that principle as set forth in Deus v. Allstate Insurance Co., 15 F.3d 506, 526 (5th Cir. 1994)); accord Bond v. Utreras, 585 F.3d 1061, 1072 (7th Cir. 2009) (“[T]he Fifth Circuit has concluded that a third party seeking to intervene to challenge a protective order after the main controversy has been disposed of must demonstrate standing.”). Adler contends that the _____________________ 1 TeamHealth also contends that Adler failed to file a pleading in accordance with Rule 24(c). We observe no such deficiency in Adler’s motion to intervene, proposed motion to unseal, and supporting declaration. See In re Beef Indus. Antitrust Litig., 589 F.2d 786, 789 (5th Cir. 1979); see also Beckman Indus., Inc. v. Int’l Ins. Co., 966 F.2d 470, 475 (9th Cir. 1992) (Movants must “describe[] the basis for intervention with sufficient specificity to allow the district court to rule.”).

4 Case: 22-40707 Document: 00516879635 Page: 5 Date Filed: 08/31/2023

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
80 F.4th 571, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-team-finance-ca5-2023.